AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $171 | -6.6% | 1,005 | 0.0% | 0.00% | – |
Q1 2023 | $183 | -61.2% | 1,005 | 0.0% | 0.00% | – |
Q4 2022 | $472 | -52.8% | 1,005 | -38.0% | 0.00% | -100.0% |
Q3 2022 | $1,000 | -50.0% | 1,621 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $2,000 | 0.0% | 1,621 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,000 | -33.3% | 1,621 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $3,000 | 0.0% | 1,621 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $3,000 | -25.0% | 1,621 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $4,000 | +33.3% | 1,621 | -24.4% | 0.00% | 0.0% |
Q4 2020 | $3,000 | -25.0% | 2,145 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $4,000 | -33.3% | 2,145 | -41.0% | 0.00% | 0.0% |
Q3 2019 | $6,000 | -25.0% | 3,633 | -8.1% | 0.00% | -20.0% |
Q2 2019 | $8,000 | -42.9% | 3,952 | 0.0% | 0.01% | -54.5% |
Q1 2019 | $14,000 | +27.3% | 3,952 | -4.1% | 0.01% | +120.0% |
Q3 2018 | $11,000 | – | 4,122 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 426,297 | $1,965,000 | 0.78% |
Vivo Capital, LLC | 527,842 | $2,433,000 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,158 | $3,772,000 | 0.20% |
NEA Management Company, LLC | 452,167 | $2,084,000 | 0.08% |
Hikari Power Ltd | 60,012 | $277,000 | 0.04% |
Baker Brothers Advisors | 496,901 | $2,291,000 | 0.02% |
QVT Financial LP | 132,077 | $531,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 214,126 | $987,000 | 0.00% |
Virtu KCG Holdings LLC | 12,472 | $57,000 | 0.00% |
Advisor Group, Inc. | 6,381 | $29,000 | 0.00% |